The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSY.L Regulatory News (SSY)

  • There is currently no data for SSY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

25 May 2011 14:15

RNS Number : 2728H
SciSys PLC
25 May 2011
 

SciSys PLC

 

TRADING STATEMENT

SciSys PLC, AIM stock code: SSY, ('SciSys' or the 'Company') - the supplier of bespoke software systems, IT based solutions and support services to the Media Broadcast, Space, Government & Defence, Environment and Application Support sectors is pleased to release the following trading statement ahead of its AGM on 26 May.

The Directors are happy to report that they currently anticipate results for the first half of 2011 will be consistent with market expectations for the full year.

 

SciSys opened the year with a comfortable order book position of £26.5m and order intake for 2011 to date is in line with expectations.

 

While its trading outlook remains positive, the Company recognises the continuing impact of the UK Government's 2010 spending review on deferrals of potential projects and programmes in the UK public sector.

 

Nevertheless with over 50% of its business derived from outside the UK and with a broad spread of customers in other markets, SciSys believes that it is sufficiently resilient to withstand any adverse conditions in the UK public sector.

 

The Company continues to show healthy cash flows which are reflected in the strength of its balance sheet. The Directors have considered the most appropriate use of surplus cash resources. Pending identification of short term acquisition opportunities, the Directors are pleased to announce that SciSys has agreed to purchase the freehold in its headquarters building, for a consideration of £5.04 million.

 

The Chippenham property provides office accommodation of 44,000 square feet over two storeys and exchange of contracts has occurred with the purchase expected to complete before the end of May 2011.

 

The Company considers that this acquisition will have an immediate positive impact on profitability by removing a substantial rent liability. The property will be sublet on a long term lease to its wholly owned subsidiary company, SciSys UK Ltd, which is currently the primary occupier, and SciSys will also seek to install other tenants in the building to generate additional income.

 

The transaction is to be funded partly from cash held by the Company, partly from a commercial loan from a UK Bank over a term of five years and partly by way of a loan from the Company's Executive Chairman, Dr Mike Love, over a term of three years.

 

The loan from Dr Love is a related party transaction under AIM rules. The interest rate applicable to the loan will be 5.25 per cent above the base rate of National Westminster Bank plc and an arrangement fee will also be payable on drawdown. That fee will be a minimum of £10,000, together with an additional £6,000 if the amount drawn down exceeds £500,000 (up to the maximum amount of the loan, being £1 million). If the Company fails to repay the loan in full on or before the due date (May 2014), Dr Love shall be entitled to convert any amount outstanding into ordinary share capital, provided that:

 

(i) the aggregate nominal value of the ordinary shares to be issued does not exceed £362,581 and/or

 

(ii) the conversion will not result in Dr Love and persons acting in concert with him carrying more than a combined interest of 29.9 per cent of the voting rights in the Company. Any conversion will be by reference to the average mid market closing price of an ordinary share over the 5 business days preceding the Company receiving notice of conversion from Dr Love.

 

 

The Directors (excluding Dr Love), having consulted with SciSys' Nominated Advisor, Canaccord Genuity, are satisfied that the terms of the loan from Dr Love are fair and reasonable insofar as the Company's shareholders are concerned.  

 

Given the Company's strong balance sheet, and subject to continued satisfactory trading, it is the Directors' current intention to continue with the progressive dividend policy announced in 2009.

 

 

For further information please contact:

SciSys PLC

 

 

Mike Love

Executive Chairman

Tel : +44 (0) 1249 466 466

Chris Cheetham

Finance Director

 

 

 

 

Winningtons

Tom Cooper

Tel : +44 (0) 797 1221972

 

 

 

Canaccord Genuity

Simon Bridges

Kit Stephenson

Tel : +44 (0) 20  7050 6500

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDMGZKZKVGMZM
Date   Source Headline
16th Sep 20147:00 amRNSContract Win
15th Sep 201410:15 amRNSTransaction in Own Shares
19th Aug 201412:10 pmRNSSIP Announcement
24th Jul 20147:00 amRNSTrading Update
17th Jul 20145:34 pmRNSSIP Announcement
2nd Jul 20144:51 pmRNSTransaction in Own Shares
23rd Jun 20141:59 pmRNSTransaction in Own Shares
18th Jun 20143:21 pmRNSSIP Announcement
30th May 201410:45 amRNSTransaction in Own Shares
22nd May 20142:15 pmRNSResult of AGM
22nd May 20147:00 amRNSAGM Trading Statement
20th May 20147:00 amRNSTransaction in Own Shares
16th May 20144:20 pmRNSSIP Announcement
13th May 20147:00 amRNSContract Win
12th May 20141:49 pmRNSDirector Declaration
9th May 20142:46 pmRNSTransaction in Own Shares
8th May 20141:18 pmRNSTransaction in Own Shares
7th May 20147:00 amRNSDirector's Dealing
22nd Apr 20142:52 pmRNSSIP Announcement
17th Apr 20144:36 pmRNSTransaction in Own Shares
16th Apr 20147:00 amRNSShare Buy-Back Programme
14th Apr 20143:20 pmRNSGrant of Share Options to Directors
14th Apr 20147:00 amRNSContract Win
11th Apr 20143:35 pmRNSAnnual Report and Accounts
11th Apr 201410:45 amRNSHolding(s) in Company
8th Apr 20147:00 amRNSContract Win
26th Mar 20147:00 amRNSUnaudited Preliminary Results
24th Jan 20147:00 amRNSPre-close Trading Update
20th Dec 20137:00 amRNSDirectorate Change
28th Nov 20137:00 amRNSExercise of Options, Issue of Equity and TVR
18th Nov 20137:00 amRNSTransaction in Own Shares
11th Nov 20133:15 pmRNSExercise of Options, Issue of Equity & TVR
7th Nov 20137:00 amRNSTransaction in Own Shares
15th Oct 201312:00 pmRNSTransaction in Own Shares
7th Oct 201311:44 amRNSHolding(s) in Company
26th Sep 20137:00 amRNSInterim Results
20th Sep 201311:50 amRNSTransaction in Own Shares
5th Aug 20133:33 pmRNSTransaction in Own Shares
25th Jul 20137:00 amRNSUpdate re: Warrior Upgrade Project
3rd Jun 20137:00 amRNSTransaction in Own Shares
23rd May 20132:09 pmRNSResult of AGM
23rd May 20137:00 amRNSTrading Statement
2nd May 20137:00 amRNSTransaction in Own Shares
24th Apr 20132:51 pmRNSTransaction in Own Shares
11th Apr 201311:30 amRNSTransaction in Own Shares
11th Apr 20137:00 amRNSGrant of Options to Directors
9th Apr 201312:35 pmRNSAvailability of Annual Report and Accounts
8th Apr 20137:00 amRNSContract win
21st Mar 20133:16 pmRNSTransaction in Own Shares
21st Mar 20137:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.